STK11 and lung carcinoma: Further confirming the dependence of AIFM2 expression on STK11 and KEAP1 mutations, significantly higher levels of AIFM2 at both protein and mRNA levels were seen in lung cancer samples with STK11/KEAP1 mutations (Figures S12G and S12H).